Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3771066014 | Product containing only famotidine in oromucosal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3771067017 | Famotidine only product in oromucosal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing only famotidine in oromucosal dose form (medicinal product form) | Is a | Product containing famotidine in oromucosal dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing only famotidine in oromucosal dose form (medicinal product form) | Is a | Product containing only famotidine (medicinal product) | true | Inferred relationship | Some | ||
Product containing only famotidine in oromucosal dose form (medicinal product form) | Has manufactured dose form | Oromucosal dose form (dose form) | true | Inferred relationship | Some | ||
Product containing only famotidine in oromucosal dose form (medicinal product form) | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
Product containing only famotidine in oromucosal dose form (medicinal product form) | Has active ingredient | Famotidine (substance) | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely famotidine 20 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | False | Product containing only famotidine in oromucosal dose form (medicinal product form) | Inferred relationship | Some | |
Product containing precisely famotidine 40 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | False | Product containing only famotidine in oromucosal dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets